PASG
Passage Bio, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
William Chou
IPO Date
2020-02-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Passage Bio, Inc.
CEO
William Chou
IPO Date
2020-02-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 10,539 |
| $5.08 |
| 21 May 2026 | Sondhi Dolan | director | A-Award | Acquired | 10,539 | $5.08 |
| 21 May 2026 | Porter Derrell | director | A-Award | Acquired | 10,539 | $5.08 |
| 21 May 2026 | Kassberg Thomas Richard | director | A-Award | Acquired | 10,539 | $5.08 |
| 21 May 2026 | Kapadia Sandip | director | A-Award | Acquired | 10,539 | $5.08 |
| 18 Mar 2026 | Borthwick Kathleen | CFO | A-Award | Acquired | 15,610 | $7.64 |
| 18 Mar 2026 | Chou William | director, officer: PRESIDENT AND CEO | A-Award | Acquired | 58,000 | $7.64 |
| 12 Jan 2026 | Chou William | director, officer: PRESIDENT AND CEO | M-Exempt | Acquired | 10,000 | $0.00 |
| 12 Jan 2026 | Chou William | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 4,076 | $18.44 |